Home
RMD
RMD News

Latest ResMed Inc. (RMD) News on October 18, 2025

2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm

StockStory

11 days ago

2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm

ResMed Insider Lowered Holding By 22% During Last Year

Simply Wall St.

13 days ago

ResMed Insider Lowered Holding By 22% During Last Year

MT Newswires

15 days ago

Resmed Insider Sold Shares Worth $823,080, According to a Recent SEC Filing

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

16 days ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Nyxoah Expands in the Middle East to Provide Wider Access to Genio

Zacks

16 days ago

Nyxoah Expands in the Middle East to Provide Wider Access to Genio

ResMed's (NYSE:RMD) investors will be pleased with their respectable 66% return over the last five years

Simply Wall St.

24 days ago

ResMed's (NYSE:RMD) investors will be pleased with their respectable 66% return over the last five years

Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring

Zacks

a month ago

Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring

MT Newswires

a month ago

Citigroup Initiates ResMed at Buy With $330 Price Target

Argus Research

a month ago

RMD: Lowering target price to $286.00

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

GlobeNewswire

a month ago

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 74% of the company

Simply Wall St.

a month ago

ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 74% of the company

How Is ResMed's Stock Performance Compared to Other Healthcare Stocks?

Barchart

a month ago

How Is ResMed's Stock Performance Compared to Other Healthcare Stocks?

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

a month ago

Here's Why ResMed (RMD) is a Strong Growth Stock

Q2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring Stocks

StockStory

a month ago

Q2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring Stocks

ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress

Insider Monkey

a month ago

ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know

StockStory

a month ago

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know

Argus Research

a month ago

RMD: Raising target price to $293.00

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

GlobeNewswire

a month ago

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

Zacks

a month ago

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

Argus Research

a month ago

RMD: Lowering target price to $285.00

22% Of This ResMed Insider's Holdings Were Sold

Simply Wall St.

2 months ago

22% Of This ResMed Insider's Holdings Were Sold

3 Reasons Investors Watch ResMed (RMD)

StockStory

2 months ago

3 Reasons Investors Watch ResMed (RMD)

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

2 months ago

Here's Why ResMed (RMD) is a Strong Growth Stock

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

GlobeNewswire

2 months ago

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Argus Research

2 months ago

RMD: Lowering target price to $299.00

Is Wall Street Bullish or Bearish on ResMed Stock?

Barchart

2 months ago

Is Wall Street Bullish or Bearish on ResMed Stock?

Respiratory Care Devices Market Landscape Report 2025-2030 Featuring Major Players - Koninklijke Philips, Medtronic, ResMed, Fisher & Paykel Healthcare, and Dragerwerk

GlobeNewswire

2 months ago

Respiratory Care Devices Market Landscape Report 2025-2030 Featuring Major Players - Koninklijke Philips, Medtronic, ResMed, Fisher & Paykel Healthcare, and Dragerwerk

ResMed Inc.'s (NYSE:RMD) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Simply Wall St.

2 months ago

ResMed Inc.'s (NYSE:RMD) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating

Investor's Business Daily

2 months ago

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

GlobeNewswire

2 months ago

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

1 Healthcare Stock Worth Investigating and 2 Facing Challenges

StockStory

2 months ago

1 Healthcare Stock Worth Investigating and 2 Facing Challenges

Argus Research

2 months ago

RMD: Raising target price to $300.00

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

GlobeNewswire

2 months ago

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

MT Newswires

2 months ago

CICC Adjusts Price Target on ResMed to $325 From $295, Maintains Outperform Rating

Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea

Zacks

2 months ago

Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea

Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed

Zacks

4 months ago

Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed

All You Need to Know About ResMed (RMD) Rating Upgrade to Buy

Zacks

4 months ago

All You Need to Know About ResMed (RMD) Rating Upgrade to Buy

Scoop Up These 4 GARP Stocks to Receive Handsome Returns

Zacks

4 months ago

Scoop Up These 4 GARP Stocks to Receive Handsome Returns

Argus Research

4 months ago

RMD: Raising target price to $269.00

Morningstar Research

4 months ago

Analyst Report: ResMed Inc.

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

StockStory

4 months ago

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

Argus Research

4 months ago

RMD: Raising target price to $265.00

Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue?

Zacks

4 months ago

Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue?

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

StockStory

4 months ago

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?

Zacks

4 months ago

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

StockStory

4 months ago

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down

StockStory

5 months ago

2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down

Newsfile

5 months ago

Max Resource Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

Newsfile

5 months ago

Carbone Restaurant Group is a GOLD Sponsor at the Centurion One Capital 6th Annual LA Summit

Energy Global

5 months ago

European Energy completes sale of Polish wind portfolio to Enea Group

Newsfile

5 months ago

Sienna Resources Inc. Announces Private Placement

First Foundation Bank review (2025): Personal and business banking with competitive online rates

Yahoo Personal Finance

5 months ago

First Foundation Bank review (2025): Personal and business banking with competitive online rates

Investing.com

5 months ago

Airbnb shares dip as Truist cuts stock to Sell on weak summer trends, valuation

Report: Slower economy doesn't dim downtown Austin's dynamism

Austin American-Statesman

5 months ago

Report: Slower economy doesn't dim downtown Austin's dynamism

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

GuruFocus.com

5 months ago

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?

Zacks

5 months ago

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

Zacks

5 months ago

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

1 Surging Stock with Exciting Potential and 2 to Avoid

StockStory

5 months ago

1 Surging Stock with Exciting Potential and 2 to Avoid

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed

TipRanks

5 months ago

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed

1 Unpopular Stock that Should Get More Attention and 2 to Brush Off

StockStory

5 months ago

1 Unpopular Stock that Should Get More Attention and 2 to Brush Off

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

5 months ago

Here's Why ResMed (RMD) is a Strong Growth Stock

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Motley Fool

5 months ago

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

GlobeNewswire

5 months ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

StockStory

5 months ago

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

Argus Research

5 months ago

RMD: Rating increased to a BUY

Argus Research

5 months ago

RMD: Raising target price to $254.00

3 Profitable Stocks to Consider Right Now

StockStory

5 months ago

3 Profitable Stocks to Consider Right Now

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

Simply Wall St.

5 months ago

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

This ResMed Insider Reduced Their Stake By 72%

Simply Wall St.

6 months ago

This ResMed Insider Reduced Their Stake By 72%

Resmed acquires independent diagnostic testing facility VirtuOx

Medical Device Network

6 months ago

Resmed acquires independent diagnostic testing facility VirtuOx

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

MedTech Dive

6 months ago

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

MT Newswires

6 months ago

ResMed Buys VirtuOx for Undisclosed sum

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

6 months ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Resmed Acquires VirtuOx

GlobeNewswire

6 months ago

Resmed Acquires VirtuOx

Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

Insider Monkey

6 months ago

Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

iRhythm Earnings: What To Look For From IRTC

StockStory

6 months ago

iRhythm Earnings: What To Look For From IRTC

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

StockStory

6 months ago

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

Zacks

6 months ago

MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks

6 months ago

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

ResMed (NYSE:RMD) Reports Strong Q3 Earnings Growth and Declares US$0.53 Dividend

Simply Wall St.

6 months ago

ResMed (NYSE:RMD) Reports Strong Q3 Earnings Growth and Declares US$0.53 Dividend

MT Newswires

6 months ago

KeyBanc Adjusts Price Target on ResMed to $274 From $269, Maintains Overweight Rating

MT Newswires

6 months ago

Jefferies Adjusts Price Target on ResMed to $245 From $270, Maintains Hold Rating

MT Newswires

6 months ago

Piper Sandler Adjusts Price Target on ResMed to $248 From $260, Maintains Neutral Rating

MT Newswires

6 months ago

Morgan Stanley Adjusts Price Target on ResMed to $286 From $280, Maintains Overweight Rating

MT Newswires

6 months ago

JPMorgan Adjusts Price Target on ResMed to $290 From $286, Maintains Overweight Rating

MT Newswires

6 months ago

Mizuho Adjusts Price Target on ResMed to $250 From $265, Maintains Outperform Rating

MT Newswires

6 months ago

Wolfe Research Adjusts Price Target on ResMed to $200 From $195, Maintains Underperform Rating

Thomson Reuters StreetEvents

6 months ago

Q3 2025 Resmed Inc Earnings Call

Morningstar Research

6 months ago

Analyst Report: ResMed Inc.

MT Newswires

6 months ago

RBC Raises Price Target on ResMed to $255 From $247, Keeps Sector Perform Rating

ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

Zacks

6 months ago

ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

ResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

6 months ago

ResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Here's What Key Metrics Tell Us About ResMed (RMD) Q3 Earnings

Zacks

6 months ago

Here's What Key Metrics Tell Us About ResMed (RMD) Q3 Earnings

ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

Zacks

6 months ago

ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

StockStory

6 months ago

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

StockStory

6 months ago

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

Resmed Names Salli Schwartz as Chief Investor Relations Officer

GlobeNewswire

6 months ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

Zacks

6 months ago

Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline

MT Newswires

6 months ago

KeyBanc Adjusts ResMed Price Target to $269 From $280, Maintains Overweight Rating

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

Zacks

6 months ago

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

Share on Social Networks: